Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03603496 · ClinicalTrials.gov registry record · Phase 4
Post-Discharge Smoking Cessation Strategies: Helping HAND 4
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,416
- Enrollment target
NCT03603496: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT03603496 is a Phase 4 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,416 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03603496, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,416 participants
- Enrollment target
Study Summary
This randomized controlled trial will compare the effectiveness of two models of post-discharge tobacco cessation treatment for adult smokers admitted to 3 U.S. hospitals.
Interventions
- DRUG Nicotine replacement therapy
- BEHAVIORAL Transitional Tobacco Care Management (TTCM)
- BEHAVIORAL eReferral to State Tobacco Quitline (QL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,416 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2020-11-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03603496
The ClinicalTrials.gov registry entry for NCT03603496 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,416 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine replacement therapy is the first listed.
NCT03603496 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03603496 about?
NCT03603496 is a clinical study titled "Post-Discharge Smoking Cessation Strategies: Helping HAND 4". This randomized controlled trial will compare the effectiveness of two models of post-discharge tobacco cessation treatment for adult smokers admitted to 3 U.S. hospitals.
What is the current status of trial NCT03603496?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,416 participants. The study started on 2018-09-01. Estimated completion is 2020-11-17.
What interventions are being tested in trial NCT03603496?
The interventions under investigation include: Nicotine replacement therapy (DRUG), Transitional Tobacco Care Management (TTCM) (BEHAVIORAL), eReferral to State Tobacco Quitline (QL) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03603496?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.